These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
473 related articles for article (PubMed ID: 25104172)
1. Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression. Yang JJ; Wang N; Yang C; Shi JY; Yu HY; Hashimoto K Biol Psychiatry; 2015 Feb; 77(3):e19-e20. PubMed ID: 25104172 [No Abstract] [Full Text] [Related]
2. Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression. Xu AJ; Niciu MJ; Lundin NB; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Machado-Vieira R; Zarate CA Neural Plast; 2015; 2015():858251. PubMed ID: 26137324 [TBL] [Abstract][Full Text] [Related]
3. Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression. Park M; Newman LE; Gold PW; Luckenbaugh DA; Yuan P; Machado-Vieira R; Zarate CA J Psychiatr Res; 2017 Jan; 84():113-118. PubMed ID: 27718369 [TBL] [Abstract][Full Text] [Related]
4. Ketamine administration in depressive disorders: a systematic review and meta-analysis. Fond G; Loundou A; Rabu C; Macgregor A; Lançon C; Brittner M; Micoulaud-Franchi JA; Richieri R; Courtet P; Abbar M; Roger M; Leboyer M; Boyer L Psychopharmacology (Berl); 2014 Sep; 231(18):3663-76. PubMed ID: 25038867 [TBL] [Abstract][Full Text] [Related]
5. Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder. Niciu MJ; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Furey ML; Zarate CA Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539512 [TBL] [Abstract][Full Text] [Related]
6. Ketamine's potential as a rapid antidepressant was overplayed. Zhang MW; Ho RC BMJ; 2015 Aug; 351():h4467. PubMed ID: 26290499 [No Abstract] [Full Text] [Related]
7. Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine. Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Slonena EE; Vande Voort JL; Brutsche NE; Zarate CA J Clin Psychiatry; 2014 Sep; 75(9):e932-8. PubMed ID: 25295436 [TBL] [Abstract][Full Text] [Related]
8. Both Serum Brain-Derived Neurotrophic Factor and Interleukin-6 Levels Are Not Associated with Therapeutic Response to Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder. Kagawa S; Mihara K; Suzuki T; Nagai G; Nakamura A; Nemoto K; Kondo T Neuropsychobiology; 2017; 75(3):145-150. PubMed ID: 29332095 [TBL] [Abstract][Full Text] [Related]
9. Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial. Murrough JW; Burdick KE; Levitch CF; Perez AM; Brallier JW; Chang LC; Foulkes A; Charney DS; Mathew SJ; Iosifescu DV Neuropsychopharmacology; 2015 Mar; 40(5):1084-90. PubMed ID: 25374095 [TBL] [Abstract][Full Text] [Related]
10. Synaptic potentiation and rapid antidepressant response to ketamine in treatment-resistant major depression: A replication study. Nugent AC; Wills KE; Gilbert JR; Zarate CA Psychiatry Res Neuroimaging; 2019 Jan; 283():64-66. PubMed ID: 30551012 [TBL] [Abstract][Full Text] [Related]
11. Hippocampal volume and the rapid antidepressant effect of ketamine. Abdallah CG; Salas R; Jackowski A; Baldwin P; Sato JR; Mathew SJ J Psychopharmacol; 2015 May; 29(5):591-5. PubMed ID: 25122038 [TBL] [Abstract][Full Text] [Related]
12. [Clinical and biological predictors of ketamine response in treatment-resistant major depression: Review]. Romeo B; Choucha W; Fossati P; Rotge JY Encephale; 2017 Aug; 43(4):354-362. PubMed ID: 27623117 [TBL] [Abstract][Full Text] [Related]
13. Ketamine's effectiveness in unipolar versus bipolar depression. Fond G; Boyer L Psychopharmacology (Berl); 2014 Nov; 231(22):4417-8. PubMed ID: 25315362 [No Abstract] [Full Text] [Related]
14. [Ketamine's antidepressant effect: focus on ketamine mechanisms of action]. De Maricourt P; Jay T; Goncalvès P; Lôo H; Gaillard R Encephale; 2014 Feb; 40(1):48-55. PubMed ID: 24434007 [TBL] [Abstract][Full Text] [Related]
15. Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects. Moaddel R; Shardell M; Khadeer M; Lovett J; Kadriu B; Ravichandran S; Morris PJ; Yuan P; Thomas CJ; Gould TD; Ferrucci L; Zarate CA Psychopharmacology (Berl); 2018 Oct; 235(10):3017-3030. PubMed ID: 30116859 [TBL] [Abstract][Full Text] [Related]
16. Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression. Niciu MJ; Shovestul BJ; Jaso BA; Farmer C; Luckenbaugh DA; Brutsche NE; Park LT; Ballard ED; Zarate CA J Affect Disord; 2018 May; 232():310-315. PubMed ID: 29501990 [TBL] [Abstract][Full Text] [Related]
17. Ketamine for treatment-resistant depression: ready or not for clinical use? Rush AJ Am J Psychiatry; 2013 Oct; 170(10):1079-81. PubMed ID: 23982324 [No Abstract] [Full Text] [Related]
18. Antidepressant Effect of Ketamine on Inflammation-Mediated Cytokine Dysregulation in Adults with Treatment-Resistant Depression: Rapid Systematic Review. Sukhram SD; Yilmaz G; Gu J Oxid Med Cell Longev; 2022; 2022():1061274. PubMed ID: 36160713 [TBL] [Abstract][Full Text] [Related]
19. Inflammatory markers and treatment outcome in treatment resistant depression: A systematic review. Yang C; Wardenaar KJ; Bosker FJ; Li J; Schoevers RA J Affect Disord; 2019 Oct; 257():640-649. PubMed ID: 31357161 [TBL] [Abstract][Full Text] [Related]
20. The role of adipokines in the rapid antidepressant effects of ketamine. Machado-Vieira R; Gold PW; Luckenbaugh DA; Ballard ED; Richards EM; Henter ID; De Sousa RT; Niciu MJ; Yuan P; Zarate CA Mol Psychiatry; 2017 Jan; 22(1):127-133. PubMed ID: 27046644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]